+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


ZIOPHARM Oncology Inc (ZIOP) - Financial and Strategic SWOT Analysis Review

  • ID: 4282003
  • SWOT Analysis
  • March 2018
  • 25 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

Ziopharm Oncology Inc (Ziopharm), formerly EasyWeb Inc is a biotechnology company that discovers and develops cancer therapies. The company develops novel gene expression, control and cell technologies to provides cell-based therapies for the treatment of cancer and graft-versus-host-disease (GvHD). It offers engineering techniques and multi-genic gene programs to develop next-generation patient and donor-derived adoptive cellular therapies. Ziopharm’s pipeline products include Ad-RTS-IL-12 and CAR/Cytokine Products. The company’s technology platforms comprise RheoSwitch therapeutic system, UltraVector, adoptive cell therapy, ActoBiotics, AttSite Recombinases and Leap among others. Its products and technologies are used in the treatment of hematologic malignancies, solid tumors and graft-versus-host-disease. Ziopharm is headquartered in Boston, Massachusetts, the US.

ZIOPHARM Oncology Inc Key Recent Developments

Mar 01, 2018: Ziopharm Oncology Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update
Feb 12, 2018: Ziopharm Oncology Presents Data on Very Rapid Production of CAR T Cells at Keystone Symposia Emerging Cellular Therapies: T Cells and Beyond
Feb 06, 2018: Ziopharm Oncology Addresses Rumors and Stock Volatility, Affirms 2018 Guidance
Jan 09, 2018: Ziopharm Oncology Provides Update on Standout Technologies During the 36th Annual J.P. Morgan Healthcare Conference
Dec 10, 2017: ZIOPHARM Announces Presentation of Data from T-Cell Therapy Programs at ASH Annual Meeting

This comprehensive SWOT profile of ZIOPHARM Oncology Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of ZIOPHARM Oncology Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
2 of 3
Section 1 - About the Company
  • ZIOPHARM Oncology Inc - Key Information
  • ZIOPHARM Oncology Inc - Overview
  • ZIOPHARM Oncology Inc - Key Employees
  • ZIOPHARM Oncology Inc - Key Employee Biographies
  • ZIOPHARM Oncology Inc - Key Operational Heads
  • ZIOPHARM Oncology Inc - Major Products and Services
  • ZIOPHARM Oncology Inc - History
  • ZIOPHARM Oncology Inc - Company Statement
  • ZIOPHARM Oncology Inc - Locations And Subsidiaries
  • ZIOPHARM Oncology Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • ZIOPHARM Oncology Inc - Business Description
  • ZIOPHARM Oncology Inc - Corporate Strategy
  • ZIOPHARM Oncology Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • ZIOPHARM Oncology Inc - Strengths
  • ZIOPHARM Oncology Inc - Weaknesses
  • ZIOPHARM Oncology Inc - Opportunities
  • ZIOPHARM Oncology Inc - Threats
  • ZIOPHARM Oncology Inc - Key Competitors
Section 3 - Company Financial Performance Charts
  • ZIOPHARM Oncology Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • ZIOPHARM Oncology Inc, Key Information
  • ZIOPHARM Oncology Inc, Key Ratios
  • ZIOPHARM Oncology Inc, Share Data
  • ZIOPHARM Oncology Inc, Major Products and Services
  • ZIOPHARM Oncology Inc, History
  • ZIOPHARM Oncology Inc, Key Employees
  • ZIOPHARM Oncology Inc, Key Employee Biographies
  • ZIOPHARM Oncology Inc, Key Operational Heads
  • ZIOPHARM Oncology Inc, Other Locations
  • ZIOPHARM Oncology Inc, Subsidiaries
  • ZIOPHARM Oncology Inc, Key Manufacturing facilities
  • ZIOPHARM Oncology Inc, Key Competitors
  • ZIOPHARM Oncology Inc, SWOT Analysis
  • ZIOPHARM Oncology Inc, Ratios based on current share price
  • ZIOPHARM Oncology Inc, Annual Ratios
  • ZIOPHARM Oncology Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • ZIOPHARM Oncology Inc, Performance Chart
  • ZIOPHARM Oncology Inc, Ratio Charts
Note: Product cover images may vary from those shown
3 of 3